Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AngioDynamics, Inc.
AngioDynamics offers 2,400,000 shares of common stock
June 23rd, 2006
AngioDynamics, Inc., (ANGO) announced that it is offering 2,400,000 shares of its common stock at a public offering price of $24.07 per share. The offering is expected to close on May 30, 2006 and is subject to the satisfaction of customary closing conditions. AngioDynamics has granted the underwriters a 30-day option to purchase up to an additional 360,000 shares of common stock to cover over-allotments, if any. RBC Capital Markets Corp. is the sole book runner and lead managing underwriter. Canaccord Adams, Inc., First Albany Capital, Inc., and KeyBanc Capital Markets are acting as co-managers for the offering. The public...
Source: Biotech Law Weekly (2006-06-23)
|
